Study of Combined RHUMAB VEGF and Capecitabine-Based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer

This study has been suspended.
Information provided by M.D. Anderson Cancer Center

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Pancreatic Cancer
2		Additional conditions recognized in this trial
			Pancreatic Neoplasms
3		More general conditions related to this trial
			Digestive System Diseases
			Digestive System Neoplasms
			Endocrine Gland Neoplasms
			Endocrine System Diseases
			Neoplasms
			Neoplasms by Site
			Pancreatic Diseases
4		Interventions listed in this trial
			Bevacizumab
5		Additional drug interventions recognized in this trial
			Capecitabine
6		More general drug interventions related to this trial
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Growth Inhibitors
			Growth Substances
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			M.D. Anderson Cancer Center